ROTARIX
Rotavirus, live attenuated (human, RIX4414)
1.5 mL · oral suspension · infants 6 weeks to under 8 months
Rotavirus
Rotavirus (infants)
ROTARIX · ROTATEQ
Two or three oral doses, started between 6 and 15 weeks of age. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
- Products
- 2
- Dose schedules
- 2
- Guidance checked
- 2026-09-27
Authorized products
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
ROTATEQ
Rotavirus, live (human-bovine reassortant, pentavalent)
2 mL · oral solution · infants 6 weeks to under 8 months
Before and after vaccination
- Bring your immunization record so earlier doses can be checked.
- Discuss a serious reaction to a previous vaccine, relevant health conditions, medicines and allergies before receiving a dose.
- After vaccination, stay where you can be observed for at least 15 minutes and report feeling faint or signs of an allergic reaction right away.
- Keep the vaccine name, date and dose in your immunization record.
Based on the Canadian Immunization Guide's administration practices and acute reactions guidance.
Pregnancy & breastfeeding
Pregnancy
Not applicable: an infant vaccine given from 6 weeks to under 8 months of age.
Breastfeeding
Not applicable; a breastfed infant receives the vaccine as usual.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
Rotavirus (ROTARIX) — two oral doses
2 dosesTwo oral doses at least 4 weeks apart, started at 6 to under 15 weeks of age and finished before 8 months.
First dose from 6 weeks of age and before 15 weeks of age; second dose at least 4 weeks later; every dose before 8 months of age. Not given to infants with severe combined immunodeficiency or a history of intussusception. An infant whose first dose was inadvertently given at 15 weeks or later still completes the series, all doses before 8 months.
ProductsROTARIX
Rotavirus (ROTATEQ) — three oral doses
3 dosesThree oral doses 4 to 10 weeks apart, started at 6 to under 15 weeks of age and finished before 8 months.
First dose from 6 weeks of age and before 15 weeks of age; later doses 4 to 10 weeks apart; every dose before 8 months of age. Not given to infants with severe combined immunodeficiency or a history of intussusception. An infant whose first dose was inadvertently given at 15 weeks or later still completes the series, all doses before 8 months.
ProductsROTATEQ
References and product information
- Rotavirus vaccines: Canadian Immunization Guide — Chapter revised April 2016
- Vaccine administration practices: Canadian Immunization Guide
- Anaphylaxis and other acute reactions: Canadian Immunization Guide
- Health Canada Drug Product Database — product records and monographs
- Pharmasist vaccine reference: ROTARIX
- Pharmasist vaccine reference: ROTATEQ
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.